scholarly journals STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma

2006 ◽  
Vol 118 (12) ◽  
pp. 2943-2947 ◽  
Author(s):  
Yao-Tsung Yeh ◽  
Fu Ou-Yang ◽  
I-Fen Chen ◽  
Sheau-Fang Yang ◽  
Yuan-Yung Wang ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Ductal Carcinoma ◽  
Estrogen Receptor Status ◽  
Receptor Status ◽  
Infiltrating Ductal Carcinoma ◽  
Breast Infiltrating Ductal Carcinoma ◽  
Negative Estrogen Receptor Status

VEGF Expression is Associated with Negative Estrogen Receptor Status in Patients with Breast Cancer

2006 ◽  
Vol 14 (1) ◽  
pp. 49-55 ◽  
Author(s):  
Dora Fuckar ◽  
Andrea Dekanic ◽  
Sanja Stifter ◽  
Elvira Mustac ◽  
Mira Krstulja ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Estrogen Receptor Status ◽  
Vegf Expression ◽  
Receptor Status ◽  
Negative Estrogen Receptor Status

scholarly journals Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status

2013 ◽  
Vol 139 (3) ◽  
pp. 639-647 ◽  
Author(s):  
Gaiane M. Rauch ◽  
Henry M. Kuerer ◽  
Marion E. Scoggins ◽  
Patricia S. Fox ◽  
Ana P. Benveniste ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Estrogen Receptor Status ◽  
Receptor Status

scholarly journals Prognostic significance of transcription factors FOXA1 and GATA-3 in ductal carcinoma in situ in terms of recurrence and estrogen receptor status

2015 ◽  
Vol 1 (2) ◽  
pp. 84
Author(s):  
Mamatha Chivukula ◽  
Jennifer Picarsic ◽  
Gautam Bulusu ◽  
Adam Brufsky ◽  
Gretchen Ahrendt ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Transcription Factors ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Estrogen Receptor Status ◽  
Prognostic Significance ◽  
Receptor Status

scholarly journals MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status

PLoS ONE ◽  
2012 ◽  
Vol 7 (6) ◽  
pp. e39011 ◽  
Author(s):  
Xin Zhou ◽  
Catalin Marian ◽  
Kepher H. Makambi ◽  
Ourania Kosti ◽  
Bhaskar V. S. Kallakury ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Local Recurrence ◽  
Estrogen Receptor Status ◽  
Receptor Status ◽  
Potential Biomarker

Immunohistochemical Demonstration of Cell Proliferation and Estrogen Receptor Status in Human Breast Cancer

2008 ◽  
Vol 40 (12) ◽  
pp. 902-907
Author(s):  
Masao Hori ◽  
Masakuni Furusato ◽  
Takashi Nikaidoh ◽  
Shigeo Aizawa
Keyword(s):  
Breast Cancer ◽  
Cell Proliferation ◽  
Estrogen Receptor ◽  
Human Breast Cancer ◽  
Estrogen Receptor Status ◽  
Human Breast ◽  
Receptor Status ◽  
Immunohistochemical Demonstration

An immunohistochemical study of estrogen and progesterone receptors in adenocarcinoma of the endometrium and in the adjacent mucosa

1995 ◽  
Vol 5 (4) ◽  
pp. 275-281 ◽  
Author(s):  
H. Kerner ◽  
E. Sabo ◽  
M. Friedman ◽  
D. Beck ◽  
O. Samare ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Endometrial Cancer ◽  
Progesterone Receptor ◽  
Estrogen Receptor Status ◽  
Endometrial Adenocarcinoma ◽  
Progesterone Receptors ◽  
Myometrial Invasion ◽  
Inverse Correlation ◽  
Immunohistochemical Analysis ◽  
Receptor Status

The immunoperoxidase stain for estrogen and progesterone receptor content in endometrial adenocarcinoma was correlated with the grade and stage, level of myometrial invasion, age and survival of the patients. Anti-estrogen and anti-progesteone receptor monoclonal antibodies were applied to paraffin-embedded tissue from hysterectomy specimens of 100 patients with adenocarcinoma of the endometrium. In 34 of the cases the receptors were studied in the endometrium adjacent to the tumor and compared to the nuclear receptor content in the carcinoma. There was a high inverse correlation between the estrogen receptor status and the grade of tumor (R= − 0.45,P= 0.006). The estrogen receptor measured in the endometrium near the tumor showed a negative correlation with the grade of the tumor (R= −0.42,P= 0.013). The estrogen, but not the progesterone, receptor content, was positively related to the age of the patient (P< 0.05). No significant correlation of the receptor status with the depth of myometrial invasion was found, despite the obvious interdependence between the grade and myometrial invasion. The progesterone receptor staining index appeared to be a distinct independent prognostic factor in endometrial cancer. The immunohistochemical analysis of the steroid hormone status in endometrial cancer therefore offers an alternative to the quantitative ligand-binding assay.

Sign in / Sign up

Export Citation Format

Share Document